SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-16-006501
Filing Date
2016-08-01
Accepted
2016-08-01 07:07:19
Documents
3
Period of Report
2016-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s103771_8k.htm 8-K 43965
2 EXHIBIT 99.1 s103771_ex99-1.htm EX-99.1 12935
3 GRAPHIC tex99-1logo.jpg GRAPHIC 10909
  Complete submission text file 0001615774-16-006501.txt   73682
Mailing Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140 (617) 674-1865
Enumeral Biomedical Holdings, Inc. (Filer) CIK: 0001561551 (see all company filings)

IRS No.: 990376434 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55415 | Film No.: 161795780
SIC: 2834 Pharmaceutical Preparations